$MRNA
AI 分析生成於 May 11, 2026
AI Score
Sell$MRNA
Moderna Inc.
$MRNANASDAQHealthcareLarge-Cap
Moderna develops mRNA-based vaccines and therapeutics including COVID-19 vaccines and a cancer pipeline.
Market Cap
$18.0B
Revenue (TTM)
$6.8B
-40.0%
Net Income (TTM)
-$3.5B
N/A
EPS (TTM)
-$9.00
P/E Ratio
N/A
Dividend Yield
0.0%
52-Week Range
$65-$170
Beta
1.82
Dimension Scores
Fundamental
35Technical
42Sentiment
48Risk / Reward
40Momentum
48Financial Health
Profitability
40weak
Growth
51weak
Liquidity
48strong
Solvency
37moderate
Efficiency
33moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $MRNA
Free · No credit card required
免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。